BioQ Pharma

Executive Summary

BioQ Pharma is a commercial-stage specialty pharmaceutical company pioneering the transformation of infusible medicines into ready-to-use, connect-and-go delivery systems through its proprietary invenious™ platform. Based in San Diego and founded in 2010, the company addresses critical inefficiencies in intravenous (IV) drug administration, including preparation errors, contamination risks, and high labor costs. Its platform is designed to enhance patient safety, simplify workflows for healthcare providers, and reduce overall healthcare costs by enabling immediate, error-free administration of medications. While the company is privately held and does not disclose financials, its focus on a high-need area of drug delivery positions it for potential partnerships and commercial expansion. The invenious™ technology has the potential to become a new standard of care in infusion therapy, offering a compelling value proposition for hospitals, clinics, and home care settings.

Upcoming Catalysts (preview)

• Q3 2026FDA Approval for First Drug-Device Combination Product75% success
• Q4 2026Strategic Partnership with a Major Pharmaceutical Company60% success
• Q2 2027Inclusion in Clinical Guidelines for IV Therapy40% success